Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature

被引:4
作者
Das, Biswadeep [1 ]
Dash, Sriya Priyadarshini [1 ]
Mohanty, Swabhiman [1 ]
Patel, Paritosh [1 ]
机构
[1] KIIT Univ, Sch Biotechnol, Bhubaneswar, India
来源
REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II | 2021年 / 1286卷
关键词
Mitochondria; Complex I; Mitochondrial DNA; Genomic DNA; OxPhos; Parkinson's disease; OXIDATIVE STRESS; COMPLEX-I; PESTICIDE EXPOSURE; RISK-FACTORS; DYSFUNCTION; BRAIN; TOXICITY; DEFECTS; NEURODEGENERATION; PATHOPHYSIOLOGY;
D O I
10.1007/978-3-030-55035-6_4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mitochondrial bioenergetics is vital for the proper functioning of cellular compartments. Impairments in mitochondrial DNA encoding the respiratory chain complexes and other assisting proteins, accumulation of intracellular reactive oxygen species, an imbalance in cellular calcium transport, or the presence of organic pollutants, high fat-ketogenic diets or toxins, and advancing age can result in complex disorders, including cancer, metabolic disease, and neurodegenerative disorders. Such manifestations are distinctly exhibited in several age-related neurodegenerative diseases, such as in Parkinson's disease (PD). Defects in complex I along with perturbed signaling pathways is a common manifestation of PD. Impaired oxidative phosphorylation could increase the susceptibility to PD. Therefore, unraveling the mechanisms of mitochondrial complexes in clinical scenarios will assist in developing potential early biomarkers and standard tests for energy failure diagnosis and assist to pave a new path for targeted therapeutics against PD.
引用
收藏
页码:65 / 76
页数:12
相关论文
共 78 条
[21]   Pesticide exposure and Parkinson's disease: Epidemiological evidence of association [J].
Freire, Carmen ;
Koifman, Sergio .
NEUROTOXICOLOGY, 2012, 33 (05) :947-971
[22]   Multiple risk factors for Parkinson's disease [J].
Gorell, JM ;
Peterson, EL ;
Rybicki, BA ;
Johnson, CC .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 217 (02) :169-174
[23]   New insights into the complex role of mitochondria in Parkinson's disease [J].
Gruenewald, Anne ;
Kumar, Kishore R. ;
Sue, Carolyn M. .
PROGRESS IN NEUROBIOLOGY, 2019, 177 :73-93
[24]   Mitochondrial DNA deletions/rearrangements in Parkinson disease and related neurodegenerative disorders [J].
Gu, GY ;
Reyes, PF ;
Golden, GT ;
Woltjer, RL ;
Hulette, C ;
Montine, TJ ;
Zhang, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (07) :634-639
[25]   Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders [J].
Islam, Md. Torequl .
NEUROLOGICAL RESEARCH, 2017, 39 (01) :73-82
[26]   Parkinson's disease: clinical features and diagnosis [J].
Jankovic, J. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (04) :368-376
[27]   Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction [J].
Jeong, Euy-Myoung ;
Chung, Jaehoon ;
Liu, Hong ;
Go, Yeongju ;
Gladstein, Scott ;
Farzaneh-Far, Afshin ;
Lewandowski, E. Douglas ;
Dudley, Samuel C., Jr. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05)
[28]   Mitochondrial permeability transition pore: a potential drug target for neurodegeneration [J].
Kalani, Komal ;
Yan, Shi Fang ;
Yan, Shirley ShiDu .
DRUG DISCOVERY TODAY, 2018, 23 (12) :1983-1989
[29]   Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis [J].
Kanthasamy, AG ;
Kitazawa, M ;
Kanthasamy, A ;
Anantharam, V .
NEUROTOXICOLOGY, 2005, 26 (04) :701-719
[30]   Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled [J].
Keeney, Paula M. ;
Xie, Jing ;
Capaldi, Roderick A. ;
Bennett, James P., Jr. .
JOURNAL OF NEUROSCIENCE, 2006, 26 (19) :5256-5264